Inhibition of premature labour with indomethacin.
Indomethacin has been tested, in addition to betasympathicomimetic therapy, in cases with an insufficient inhibition of premature labour. An oral dose of 200 mg indomethacin per day was given for two days, 150 mg for additional two days and, subsequently, 100 mg for the subsequent days. The mean duration of therapy was 8 days. No maternal or foetal side-effects were observed.
D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000209:etiology; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D014427:Twins
D007213:Indomethacin